{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:40:08Z","timestamp":1793295608047,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802389"],"award-info":[{"award-number":["81802389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qinglan Project in Jiangsu Province"},{"name":"A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is a malignancy with high incidence and mortality rates worldwide. Alcohol dehydrogenases (ADHs) are huge family of dehydrogenase enzymes and associated with the prognosis of various cancers. However, comprehensive analysis of prognostic implications related to ADHs in HCC is still lacking and largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression profiles and corresponding clinical information of HCC were obtained from The Cancer Genome Atlas (TCGA). Wilcoxon signed-rank test was employed to evaluate the expression of ADHs. Cox regression and Kaplan-Meier analyses were used to investigate the association between clinicopathological characteristics and survival. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analyses were performed and visualized using R\/BiocManager package.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that the expression of ADH1A, ADH1B, ADH1C, ADH4, and ADH6 was significantly downregulated in HCC samples compared to normal liver samples. Our univariate and multivariate Cox regression analyses results showed that high expression of ADH1A, ADH1B, ADH1C, ADH4, and ADH6 was considered as an independent factor with an improved prognosis for the survival of HCC patients. Moreover, our Kaplan-Meier analysis results also revealed that high expression of AHD1A, ADH1B, ADH1C, ADH4, and ADH6 was significantly associated with good survival rate in HCC patients. In addition, GO, KEGG, and GSEA analyses unveiled several oncogenic signaling pathways were negatively associated high expression of ADHs in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the present study, our results provide the potential prognostic biomarkers or molecular targets for the patients with HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07689-1","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T06:04:02Z","timestamp":1607321042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3995-718X","authenticated-orcid":false,"given":"Xiangye","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"issue":"6","key":"7689_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"7689_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7689_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/2213988501812010009","volume":"12","author":"AK Singh","year":"2018","unstructured":"Singh AK, Kumar R, Pandey AK. Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr Chem Genom Transl Med. 2018;12:9\u201326.","journal-title":"Curr Chem Genom Transl Med"},{"key":"7689_CR4","doi-asserted-by":"crossref","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477\u201391 e1.","DOI":"10.1053\/j.gastro.2018.08.065"},{"issue":"8","key":"7689_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","volume":"7","author":"JD Yang","year":"2010","unstructured":"Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448\u201358.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"7689_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/ijms20061358","volume":"20","author":"T Kanda","year":"2019","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci. 2019;20(6):1358.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"7689_CR7","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/liv.12818","volume":"35","author":"JW Park","year":"2015","unstructured":"Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study. Liver Int. 2015;35(9):2155\u201366.","journal-title":"Liver Int"},{"issue":"5 Suppl 1","key":"7689_CR8","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","volume":"127","author":"TR Morgan","year":"2004","unstructured":"Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S87\u201396.","journal-title":"Gastroenterology"},{"issue":"43","key":"7689_CR9","doi-asserted-by":"publisher","first-page":"15943","DOI":"10.3748\/wjg.v20.i43.15943","volume":"20","author":"G Testino","year":"2014","unstructured":"Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: a review and a point of view. World J Gastroenterol. 2014;20(43):15943\u201354.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"7689_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12263-009-0154-1","volume":"5","author":"HK Seitz","year":"2010","unstructured":"Seitz HK, Stickel F. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr. 2010;5(2):121\u20138.","journal-title":"Genes Nutr"},{"issue":"4","key":"7689_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667\u201385.","journal-title":"Clin Liver Dis"},{"issue":"12","key":"7689_CR12","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/acer.13904","volume":"42","author":"HJ Edenberg","year":"2018","unstructured":"Edenberg HJ, McClintick JN. Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review. Alcohol Clin Exp Res. 2018;42(12):2281\u201397.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"7689_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/acer.12340","volume":"38","author":"S Jairam","year":"2014","unstructured":"Jairam S, Edenberg HJ. Single-nucleotide polymorphisms interact to affect ADH7 transcription. Alcohol Clin Exp Res. 2014;38(4):921\u20139.","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"7689_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/jcla.20241","volume":"22","author":"W Jelski","year":"2008","unstructured":"Jelski W, Zalewski B, Szmitkowski M. Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer. J Clin Lab Anal. 2008;22(3):204\u20139.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"7689_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ng.151","volume":"40","author":"M Hashibe","year":"2008","unstructured":"Hashibe M, Mckay JD, Curado MP, Oliveira JC, Koifman S, Koifman R, et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet. 2008;40(6):707\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"7689_CR16","first-page":"31","volume":"9","author":"J Ding","year":"2008","unstructured":"Ding J, Li S, Wu J, Gao C, Zhou J, Cao H, et al. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population. Asian Pac J Cancer Prev. 2008;9(1):31\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"7689_CR17","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/jgh.12948","volume":"30","author":"H Abe","year":"2015","unstructured":"Abe H, Aida Y, Seki N, Sugita T, Tomita Y, Nagano T, et al. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in east Asian alcoholic liver cirrhosis. J Gastroenterol Hepatol. 2015;30(9):1376\u201383.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"7689_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/ijc.21583","volume":"118","author":"N Homann","year":"2006","unstructured":"Homann N, Stickel F, Konig IR, Jacobs A, Junghanns K, Benesova M, et al. Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer. 2006;118(8):1998\u20132002.","journal-title":"Int J Cancer"},{"key":"7689_CR19","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.12659\/MSM.910026","volume":"24","author":"P Wang","year":"2018","unstructured":"Wang P, Zhang L, Huang C, Huang P, Zhang J. Distinct prognostic values of alcohol dehydrogenase family members for non-small cell lung cancer. Med Sci Monit. 2018;24:3578\u201390.","journal-title":"Med Sci Monit"},{"issue":"4","key":"7689_CR20","first-page":"5505","volume":"15","author":"E Guo","year":"2018","unstructured":"Guo E, Wei H, Liao X, Xu Y, Li S, Zeng X. Prognostic value of alcohol dehydrogenase mRNA expression in gastric cancer. Oncol Lett. 2018;15(4):5505\u201316.","journal-title":"Oncol Lett"},{"issue":"43","key":"7689_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7689_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.lfs.2019.04.068","volume":"228","author":"H Cao","year":"2019","unstructured":"Cao H, Chu X, Wang Z, Guo C, Shao S, Xiao J, et al. High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells. Life Sci. 2019;228:128\u201334.","journal-title":"Life Sci"},{"key":"7689_CR23","unstructured":"Carlson M. GO.db: A set of annotation maps describing the entire Gene Ontology. R package version 3.8.2. 2019."},{"key":"7689_CR24","unstructured":"Carlson M. KEGG. db: a set of annotation maps for KEGG. R package version 3.1.2. 2016."},{"key":"7689_CR25","volume-title":"R: a language and environment for statistical computing","author":"Team RC","year":"2013","unstructured":"Team RC. R: a language and environment for statistical computing; 2013."},{"issue":"1","key":"7689_CR26","first-page":"38","volume":"30","author":"HK Seitz","year":"2007","unstructured":"Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health. 2007;30(1):38\u201341 44-37.","journal-title":"Alcohol Res Health"},{"issue":"8","key":"7689_CR27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893\u2013907.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"7689_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1124\/jpet.118.249425","volume":"367","author":"N Gao","year":"2018","unstructured":"Gao N, Li J, Li MR, Qi B, Wang Z, Wang GJ, et al. Higher activity of alcohol dehydrogenase is correlated with hepatic fibrogenesis. J Pharmacol Exp Ther. 2018;367(3):473\u201382.","journal-title":"J Pharmacol Exp Ther"},{"key":"7689_CR29","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2147\/OTT.S140221","volume":"10","author":"X Liao","year":"2017","unstructured":"Liao X, Huang R, Liu X, Han C, Yu L, Wang S, et al. Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma. Onco Targets Ther. 2017;10:3719\u201332.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"7689_CR30","first-page":"4457","volume":"10","author":"L Shang","year":"2017","unstructured":"Shang L, Zhu G, Su H, Chen B, Ye X, Chen X, et al. Identification of alcohol dehydrogenase as a potential prognostic marker in HBV-related hepatocellular carcinoma. Int J Clin Exp Med. 2017;10(3):4457\u201372.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"7689_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/MPA.0b013e3181bab6c2","volume":"39","author":"B Mohelnikova-Duchonova","year":"2010","unstructured":"Mohelnikova-Duchonova B, Vrana D, Holcatova I, Ryska M, Smerhovsky Z, Soucek P. CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas. 2010;39(2):144\u20138.","journal-title":"Pancreas"},{"issue":"1","key":"7689_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12885-017-3713-7","volume":"17","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Bankura B, Ghosh S, Saha ML, Pattanayak AK, Ghatak S, et al. Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India. BMC Cancer. 2017;17(1):782.","journal-title":"BMC Cancer"},{"issue":"9","key":"7689_CR33","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1007\/s10620-007-0153-2","volume":"53","author":"W Jelski","year":"2008","unstructured":"Jelski W, Zalewski B, Szmitkowski M. The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancer. Dig Dis Sci. 2008;53(9):2550\u20135.","journal-title":"Dig Dis Sci"},{"key":"7689_CR34","doi-asserted-by":"crossref","unstructured":"Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019;179(2):561\u201377 e22.","DOI":"10.1016\/j.cell.2019.08.052"},{"key":"7689_CR35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fonc.2020.01210","volume":"10","author":"Q Chen","year":"2020","unstructured":"Chen Q, Li F, Gao Y, Xu G, Liang L, Xu J. Identification of energy metabolism genes for the prediction of survival in hepatocellular carcinoma. Front Oncol. 2020;10:1210.","journal-title":"Front Oncol"},{"issue":"4","key":"7689_CR36","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s12032-011-0126-3","volume":"29","author":"RR Wei","year":"2012","unstructured":"Wei RR, Zhang MY, Rao HL, Pu HY, Zhang HZ, Wang HY. Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma. Med Oncol. 2012;29(4):2737\u201343.","journal-title":"Med Oncol"},{"issue":"1","key":"7689_CR37","first-page":"170","volume":"23","author":"K Blagotinsek","year":"2017","unstructured":"Blagotinsek K, Rozman D. Targeting signalling pathways in hepatocellular carcinoma. Curr Pharm Des. 2017;23(1):170\u20135.","journal-title":"Curr Pharm Des"},{"issue":"Database issue","key":"7689_CR38","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2009","unstructured":"Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al. PID: the pathway interaction database. Nucleic Acids Res. 2009;37(Database issue):D674\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"7689_CR39","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","volume":"21","author":"LM Karnitz","year":"2015","unstructured":"Karnitz LM, Zou L. Molecular pathways: targeting ATR in cancer therapy. Clin Cancer Res. 2015;21(21):4780\u20135.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"7689_CR40","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","volume":"71","author":"P Raychaudhuri","year":"2011","unstructured":"Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res. 2011;71(13):4329\u201333.","journal-title":"Cancer Res"},{"issue":"1","key":"7689_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12885-019-6110-6","volume":"19","author":"M Lu","year":"2019","unstructured":"Lu M, Hartmann D, Braren R, Gupta A, Wang B, Wang Y, et al. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis. BMC Cancer. 2019;19(1):887.","journal-title":"BMC Cancer"},{"key":"7689_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fonc.2019.01000","volume":"9","author":"KR Zahid","year":"2019","unstructured":"Zahid KR, Yao S, Khan ARR, Raza U, Gou D. mTOR\/HDAC1 crosstalk mediated suppression of ADH1A and ALDH2 links alcohol metabolism to hepatocellular carcinoma onset and progression in silico. Front Oncol. 2019;9:1000.","journal-title":"Front Oncol"},{"issue":"6","key":"7689_CR43","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.7150\/jca.26847","volume":"10","author":"Q Huang","year":"2019","unstructured":"Huang Q, Li J, Zheng J, Wei A. The carcinogenic role of the Notch signaling pathway in the development of hepatocellular carcinoma. J Cancer. 2019;10(6):1570\u20139.","journal-title":"J Cancer"},{"issue":"1","key":"7689_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trecan.2019.11.004","volume":"6","author":"Q Tang","year":"2020","unstructured":"Tang Q, Su Z, Gu W, Rustgi AK. Mutant p53 on the path to metastasis. Trends Cancer. 2020;6(1):62\u201373.","journal-title":"Trends Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-07689-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T06:18:37Z","timestamp":1607321917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07689-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7689"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07689-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-48478\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-48478\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-48478\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics approval was required for the present study. The datasets analyzed in the present study are publicly available.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1204"}}